Drug Development

Over 400 Drugs In Pipeline for Cancer, PhRMA Survey Says

Published in Cancer Weekly, April 17th, 2001

Pharmaceutical researchers are developing 402 new weapons to target cancer, many of them cutting-edge medicines that will be alternatives to standard radiation and chemotherapy treatments that are frequently destructive to healthy tissue as well as cancerous cells, according to a new survey by the Pharmaceutical Research and Manufacturers of America (PhRMA).

"What researchers are working on today will radically change the way we will think of cancer treatment in the future. There's a great emphasis on zeroing in on the root causes of disease," said PhRMA president Alan F. Holmer. "The 402 medicines in the pipeline for cancer represent almost a doubling of the research...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2001-04-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry